Polymyxin E7
| Internal ID | 7b5c8371-b901-4e30-8ab6-363ed24b8a4d |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-3-(1-hydroxyethyl)-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-7-methyloctanamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C53H100N16O13/c1-28(2)12-10-9-11-13-41(72)60-33(14-20-54)48(77)69-43(32(8)71)53(82)65-36(17-23-57)45(74)64-38-19-25-59-52(81)42(31(7)70)68-49(78)37(18-24-58)62-44(73)34(15-21-55)63-50(79)39(26-29(3)4)67-51(80)40(27-30(5)6)66-46(75)35(16-22-56)61-47(38)76/h28-40,42-43,70-71H,9-27,54-58H2,1-8H3,(H,59,81)(H,60,72)(H,61,76)(H,62,73)(H,63,79)(H,64,74)(H,65,82)(H,66,75)(H,67,80)(H,68,78)(H,69,77) |
| InChI Key | IEGKXZISTLHOJK-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C53H100N16O13 |
| Molecular Weight | 1169.50 g/mol |
| Exact Mass | 1168.76557731 g/mol |
| Topological Polar Surface Area (TPSA) | 491.00 Ų |
| XlogP | -2.80 |
| Atomic LogP (AlogP) | -5.44 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 18 |
| Rotatable Bonds | 29 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4913 | 49.13% |
| Caco-2 | - | 0.8595 | 85.95% |
| Blood Brain Barrier | - | 0.8000 | 80.00% |
| Human oral bioavailability | - | 0.8000 | 80.00% |
| Subcellular localzation | Mitochondria | 0.5098 | 50.98% |
| OATP2B1 inhibitior | - | 0.8610 | 86.10% |
| OATP1B1 inhibitior | + | 0.9249 | 92.49% |
| OATP1B3 inhibitior | + | 0.9118 | 91.18% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 1.0000 | 100.00% |
| BSEP inhibitior | + | 0.9063 | 90.63% |
| P-glycoprotein inhibitior | + | 0.7401 | 74.01% |
| P-glycoprotein substrate | + | 0.8678 | 86.78% |
| CYP3A4 substrate | + | 0.6775 | 67.75% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.7691 | 76.91% |
| CYP3A4 inhibition | - | 0.9174 | 91.74% |
| CYP2C9 inhibition | - | 0.9493 | 94.93% |
| CYP2C19 inhibition | - | 0.9267 | 92.67% |
| CYP2D6 inhibition | - | 0.9379 | 93.79% |
| CYP1A2 inhibition | - | 0.9516 | 95.16% |
| CYP2C8 inhibition | + | 0.4679 | 46.79% |
| CYP inhibitory promiscuity | - | 0.9951 | 99.51% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6342 | 63.42% |
| Eye corrosion | - | 0.9819 | 98.19% |
| Eye irritation | - | 0.8960 | 89.60% |
| Skin irritation | - | 0.7654 | 76.54% |
| Skin corrosion | - | 0.9207 | 92.07% |
| Ames mutagenesis | - | 0.7700 | 77.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3759 | 37.59% |
| Micronuclear | + | 0.7300 | 73.00% |
| Hepatotoxicity | - | 0.7700 | 77.00% |
| skin sensitisation | - | 0.8785 | 87.85% |
| Respiratory toxicity | + | 0.6667 | 66.67% |
| Reproductive toxicity | + | 0.8000 | 80.00% |
| Mitochondrial toxicity | + | 0.6875 | 68.75% |
| Nephrotoxicity | + | 0.8461 | 84.61% |
| Acute Oral Toxicity (c) | III | 0.7587 | 75.87% |
| Estrogen receptor binding | + | 0.7455 | 74.55% |
| Androgen receptor binding | + | 0.6097 | 60.97% |
| Thyroid receptor binding | - | 0.6516 | 65.16% |
| Glucocorticoid receptor binding | + | 0.5748 | 57.48% |
| Aromatase binding | + | 0.6985 | 69.85% |
| PPAR gamma | + | 0.7393 | 73.93% |
| Honey bee toxicity | - | 0.8244 | 82.44% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | + | 0.5324 | 53.24% |
| Fish aquatic toxicity | - | 0.7330 | 73.30% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.36% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.50% | 96.09% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.41% | 94.45% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 98.31% | 98.05% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.26% | 96.61% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.94% | 91.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.92% | 97.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.84% | 99.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.50% | 94.45% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.24% | 88.42% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 95.30% | 96.11% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 95.12% | 97.23% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 95.08% | 98.33% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.05% | 90.71% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 93.52% | 94.55% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 93.46% | 95.20% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.27% | 96.47% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 92.81% | 94.66% |
| CHEMBL4302 | P08183 | P-glycoprotein 1 | 92.13% | 92.98% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 91.98% | 92.97% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 91.72% | 96.06% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 91.61% | 95.50% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 91.24% | 93.18% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 90.88% | 95.00% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 89.63% | 98.94% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 89.56% | 95.93% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 89.32% | 98.24% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 89.10% | 90.08% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 89.05% | 96.33% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 88.93% | 92.88% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 88.54% | 96.90% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 88.23% | 95.92% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 87.94% | 94.75% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.92% | 97.14% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 87.77% | 91.03% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 86.64% | 100.00% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 86.52% | 93.03% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 86.41% | 98.03% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 86.16% | 90.24% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 86.02% | 95.71% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.66% | 95.89% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 85.61% | 89.50% |
| CHEMBL1801 | P00747 | Plasminogen | 84.77% | 92.44% |
| CHEMBL1829 | O15379 | Histone deacetylase 3 | 84.60% | 95.00% |
| CHEMBL1865 | Q9UBN7 | Histone deacetylase 6 | 83.81% | 97.03% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.46% | 93.00% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 83.31% | 92.50% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 83.22% | 82.86% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.04% | 95.38% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 82.79% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.67% | 93.56% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 82.54% | 94.80% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 81.01% | 93.10% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 80.69% | 97.79% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 80.52% | 96.67% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 80.25% | 100.00% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 80.24% | 82.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 73003771 |
| LOTUS | LTS0228841 |
| wikiData | Q77512570 |